In the following review article, we aim at reviewing the evidence related to the impact of GLP-1 RAs, on gastrointestinal procedures, mainly EGDs and colonoscopies, and their implications on the peri-operative period
doi: 10.1038/cr.2015.68 57 Palsson-McDermottEMCurtisAMGoelGLauterbachMASheedyFJGleesonLEet al
Some context worth noting: - Generic pricing could fall to ~50% of brand cost with two generics, and ~35% with three or more - Canadian insurers paid $77M in weight-loss drug claims in 2024, double the year before - 13 cancers are linked to obesity, and 2030% of cancer patients also have diabetes, heart disease, or mental health conditions, treating these in isolation misses the bigger picture, and leaves real clinical and financial value on the table
Maiseyeu, A
In fact, a lot of guys wonder if it even fits with their new TRT routine
Members frequently note a decrease in alcohol desire and enjoyment while on GLP-1 medications